- Issuer ticker
-
ITOS
- Reported as of
-
22 Mar 2022
- Net transaction value
-
+$1,625,489
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
24 Mar 2022, 21:00:25 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Aaron I. Davis
Key filing fact
Davis Aaron I. filed Form 4 for iTeos Therapeutics, Inc. (ITOS) on 24 Mar 2022.
Key facts
- This page summarizes Davis Aaron I.'s Form 4 filing for iTeos Therapeutics, Inc. (ITOS).
- 4 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 24 Mar 2022, 21:00.
Change
- Previous filing in this sequence was filed on 18 Jan 2022.
- Current net transaction value: +$1,625,489.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ITOS
transaction
Common Stock
Purchase
- Transaction value
- $678,938
- Shares
- +21,300
- Change %
- +0.68%
- Price
-
$31.88
- Shares after
- 3,163,358
- Date
- 22 Mar 2022
- Ownership
- See footnote
- Footnotes
- F1
ITOS
transaction
Common Stock
Purchase
- Transaction value
- $122,432
- Shares
- +3,700
- Change %
- +0.12%
- Price
-
$33.09
- Shares after
- 3,167,058
- Date
- 22 Mar 2022
- Ownership
- See footnote
- Footnotes
- F1
ITOS
transaction
Common Stock
Purchase
- Transaction value
- $167,139
- Shares
- +5,000
- Change %
- +0.16%
- Price
-
$33.43
- Shares after
- 3,172,058
- Date
- 22 Mar 2022
- Ownership
- See footnote
- Footnotes
- F1
ITOS
transaction
Common Stock
Purchase
- Transaction value
- $656,980
- Shares
- +20,000
- Change %
- +0.63%
- Price
-
$32.85
- Shares after
- 3,192,058
- Date
- 23 Mar 2022
- Ownership
- See footnote
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote